Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. We conducted a multicenter, randomized, open-label, three-group, controlled trial involving hospitalized patients...

Full description

Saved in:

Bibliographic Details
Published in:	New England Journal of Medicine 2020-11, Vol.383 (21), p.2041
Main Authors:	Cavalcanti, Alexandre B, Zampieri, Fernando G, Rosa, Regis G, Azevedo, Luciano C P, Veiga, Viviane C, Avezum, Alvaro, Damiani, Lucas P, Marcadenti, Aline, Kawano-Dourado, Letícia, Lisboa, Thiago, Junqueira, Debora L M, de Barros E Silva, Pedro G M, Tramujas, Lucas, Abreu-Silva, Erlon O, Laranjeira, Ligia N, Soares, Aline T, Echenique, Leandro S, Pereira, Adriano J, Freitas, Flávio G R, Gebara, Otávio C E, Dantas, Vicente C S, Furtado, Remo H M, Milan, Eveline P, Golin, Nicole A, Cardoso, Fábio F, Maia, Israel S, Hoffmann Filho, Conrado R, Kormann, Adrian P M, Amazonas, Roberto B, Bocchi de Oliveira, Monalisa F, Serpa-Neto, Ary, Falavigna, Maicon, Lopes, Renato D, Machado, Flávia R, Berwanger, Otavio
Format:	Article
Language:	English
Subjects:	Adult Aged Aged, 80 and over Antiviral Agents - administration & dosage Antiviral Agents - therapeutic use Azithromycin - administration & dosage Azithromycin - therapeutic use Betacoronavirus Brazil Coronavirus Infections - drug therapy COVID-19 Drug Therapy, Combination Female Hospitalization Humans Hydroxychloroquine - administration & dosage Hydroxychloroquine - therapeutic use Male Middle Aged Pandemics Patient Acuity Pneumonia, Viral - drug therapy SARS-CoV-2 Treatment Failure
Citations:	Items that cite this one
Online Access:	Request full text
Tags:	Add Tag No Tags, Be the first to tag this record!